|
|
||||||||
and IL-1
: implication
for suppression of osteoblastic differentiation
1 Department of Oral and Maxillofacial Surgery, 2 Second Department of Internal Medicine, Faculty of Medicine, and 3 Health Service Center, University of Tokyo, Bunkyo-ku, Tokyo 113-8865, Japan
To determine the roles of nitric oxide
(NO) and its metabolite, peroxynitrite (ONOO
), on
osteoblastic activation, we investigated the effects of a NO
donor [ethanamine, 2,2'-(hydroxynitrosohydrazono)bis-
(dNO)], an O
2 donor
(pyrogallol), and an ONOO
scavenger (urate) on
alkaline phosphatase (ALPase) activity and osteocalcin gene expression,
which are indexes of osteoblastic differentiation. dNO elevated ALPase
activity in the osteogenic MC3T3-E1 cell line. The combination of dNO
and pyrogallol reduced both ALPase activity and osteocalcin gene
expression. Because both indexes were recovered by urate,
ONOO
, unlike NO itself, inhibited the osteoblastic
differentiation. Furthermore, treatment with a combination of the
proinflammatory cytokines tumor necrosis factor-
(TNF-
) and
interleukin-1
(IL-1
) was found to yield ONOO
as well as NO and O
2. The reductions
in ALPase activity and osteocalcin gene expression were also restored
by urate. We conclude that ONOO
produced by TNF-
and IL-1
, but not NO per se, would overcome the stimulatory effect
of NO on osteoblastic activity and inhibit osteoblastic differentiation.
nitric oxide; osteoblasts; proinflammatory cytokines
This article has been cited by other articles:
![]() |
T. Abe, H. Hikiji, W. S. Shin, N. Koshikiya, S.-i. Shima, J. Nakata, T. Susami, T. Takato, and T. Toyo-oka Targeting of iNOS with antisense DNA plasmid reduces cytokine-induced inhibition of osteoblastic activity Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E614 - E621. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |